Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

被引：0
|
作者：
Morozova, Elena V.
Moiseev, Ivan S.
Barabanshikova, Maria V.
Darskaya, Elena I.
Bondarenko, Sergey N.
Zubarovskaya, Ludmila S.
Baykov, Vadim
Alyanski, Alexandr L.
Barkhatov, Ildar M.
Zander, Axel R.
Afanasyev, Boris V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
    Morozova, Elena Vladislavovna
    Barabanshikova, Maria Vladimirovna
    Moiseev, Ivan Sergeevich
    Shakirova, Alena Igorevna
    Barhatov, Ildar Munerovich
    Ushal, Inna Edvardovna
    Rodionov, Gennadij Georgievich
    Moiseev, Sergey Ivanovich
    Surkova, Elena Arkadjevna
    Lapin, Sergey Vladimirovich
    Vlasova, Julia Jurjevna
    Rudakova, Tatjana Alexandrovna
    Darskaya, Elena Igorevna
    Baykov, Vadim Valentinovich
    Alyanski, Alksandr Leonidovich
    Bondarenko, Sergey Nikolaevich
    Afanasyev, Boris Vladimirovich
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 158 - 165
  • [2] Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease Prophylaxis
    Volodin, Leonid
    Ballen, Karen K.
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 124 - 125
  • [3] Ruxolitinib for Therapy of Graft-versus-Host Disease
    Neumann, Thomas
    Schneidewind, Laila
    Weigel, Martin
    Plis, Andrzej
    Vaizian, Rem
    Schmidt, Christian A.
    Krueger, William
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [4] Ruxolitinib for Chronic Graft-versus-Host Disease
    Gratwohl, Alois
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1631 - 1631
  • [5] Ruxolitinib for treatment of Graft-versus-Host Disease
    Krueger, W. H.
    Neumann, T.
    Weigel, M.
    Plis, A.
    Schneidewind, L.
    Vaizian, R.
    Schmidt, C. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 70 - 71
  • [6] Ruxolitinib for therapy of graft-versus-host disease
    Plis, A.
    Neumann, T.
    Schneidewind, L.
    Weigel, M.
    Vaizian, R.
    Schmidt, C.
    Krueger, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 205 - 205
  • [7] Ruxolitinib for Acute Graft-versus-Host Disease
    Gratwohl, Alois
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 501 - 501
  • [8] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [9] Ruxolitinib for Chronic Graft-versus-Host Disease REPLY
    Zeiser, Robert
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1632 - 1632
  • [10] Tongue graft-versus-host disease: remission with ruxolitinib
    Grafanaki, Katerina
    Lygeros, Spyridon
    Spyridonidis, Alexandros
    Liga, Maria
    BMJ CASE REPORTS, 2022, 15 (05)
12345